Prostate Cancer
📧 Sign up to get email alerts when something new happens for Prostate Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2021-02-18Clinical Trial Update: Dovitinib(TKI258) in Patients With Castration-resistant Prostate Cancer [Phase 2]
Phase 2 clinical trial of Dovitinib (TKI258) in patients with castration-resistant prostate cancer has completed.
-
CLINICAL_TRIALS trial_result · 2021-02-16Clinical Trial Update: Study of the Effect of GTx-758 on Serum PSA and Testosterone in Men With Prostate Cancer [Phase 2]
Phase 2 clinical trial update evaluating the effect of GTx-758 on serum PSA and testosterone in men with prostate cancer.
-
CLINICAL_TRIALS trial_result · 2021-02-12Clinical Trial Update: MSG Use With 18F-DCFPyL PET/CT Imaging [NA]
A completed clinical trial evaluating the use of monosodium glutamate (MSG) with 18F-DCFPyL PET/CT imaging in prostate cancer, with results …
-
CLINICAL_TRIALS trial_result · 2021-02-12Clinical Trial Update: Rucaparib and Nivolumab in Patients With Prostate or Endometrial Cancer [Phase 1, Phase 2]
Phase 1/2 clinical trial of rucaparib combined with nivolumab in prostate and endometrial cancer was terminated with posted results.
-
CLINICAL_TRIALS trial_result · 2021-02-09Clinical Trial Update: Prostate Cancer Screening in Men With Germline BRCA2 Mutations
Clinical trial update on prostate cancer screening in men with germline BRCA2 mutations; study completed with results posted.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2021-02-09Clinical Trial Update: HDR Brachytherapy vs. LDR Brachytherapy Monotherapy in Localized Prostate Cancer [Phase 2]
A Phase 2 clinical trial comparing HDR brachytherapy to LDR brachytherapy as monotherapy for localized prostate cancer has completed.
-
CLINICAL_TRIALS trial_result · 2021-02-08Clinical Trial Update: Staging Prostate Cancer With Hybrid C11-Choline PET/MR and mpMRI [Phase 3]
Phase 3 trial update evaluating hybrid C11-Choline PET/MR and mpMRI for staging prostate cancer has completed; results posted in 2021.
-
CLINICAL_TRIALS trial_result · 2021-02-08Clinical Trial Update: Neoadjuvant Therapy of Abiraterone Plus ADT for Intraductal Carcinoma of the Prostate [Phase 2]
Phase 2 trial examining neoadjuvant abiraterone plus androgen deprivation therapy for intraductal carcinoma of the prostate.
-
CLINICAL_TRIALS trial_result · 2021-02-02Clinical Trial Update: A Prospective Study on 18F-DCFPyL PET/CT Imaging in Biochemical Recurrence of Prostate Cancer [Phase 3]
Prospective Phase 3 trial evaluating 18F-DCFPyL PET/CT imaging in biochemical recurrence of prostate cancer.
-
FDA approval · 2021-02-01FDA Approved: LEUPROLIDE ACETATE — Supplemental Application (Sandoz Inc)
The FDA approved a supplemental application for Leuprolide acetate submitted by Sandoz Inc. This action approves changes under the generic d…
-
CLINICAL_TRIALS trial_result · 2021-02-01Clinical Trial Update: A Study for Patients With Prostate Cancer to See Whether Delivering an Extra Dose of Radiation to Parts of the Body With More Cancer is Better Than Standard Treatment in Which the Same Dose of Radiation is Given Throughout the Prostate Gland [Phase 1, Phase 2]
A combined Phase 1/2 trial evaluating whether an escalated dose of radiation to focal cancerous areas, as opposed to uniform dosing througho…
-
CLINICAL_TRIALS trial_result · 2021-01-27Clinical Trial Update: Immunization With NY-ESO-1 Protein Combined With CpG 7909 in Patients With Prostate Cancer [Phase 1]
Phase 1 trial evaluating NY-ESO-1 protein with CpG 7909 in prostate cancer has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2021-01-26Clinical Trial Update: Safety and Tolerability of a Modified Vaccinia Ankara (MVA)-Based Vaccine Modified to Express Brachyury and T-cell Costimulatory Molecules (MVA-Brachyury-TRICOM) [Phase 1]
Phase 1 trial evaluating safety and tolerability of an MVA-based vaccine expressing brachyury and T-cell costimulatory molecules (MVA-Brachy…
-
CLINICAL_TRIALS research · 2021-01-26Clinical Trial Update: Validation of a Screening Tool in Geriatric Oncology [NA]
A completed clinical trial evaluating a screening tool in geriatric oncology with results posted.
-
CLINICAL_TRIALS trial_result · 2021-01-26Clinical Trial Update: SHIP (Selinexor in Hormone Insensitive Prostate Cancer) [Phase 2]
Phase 2 trial SHIP investigating selinexor in hormone-insensitive prostate cancer was terminated; results posted in 2021.
-
CLINICAL_TRIALS trial_result · 2021-01-25Clinical Trial Update: A Phase III Intensity Radiotherapy Dose Escalation for Prostate Cancer Using Hypofractionation [Phase 3]
A Phase III trial studying intensity-modulated hypofractionated radiotherapy dose escalation in prostate cancer; results status is unknown i…
-
CLINICAL_TRIALS trial_result · 2021-01-25Clinical Trial Update: Sipuleucel-T With Immediate vs. Delayed Cytotoxic T-Lymphocyte-Associated Protein 4 (CTLA-4) Blockade for Prostate Cancer [Phase 2]
Phase 2 trial evaluating Sipuleucel-T with immediate versus delayed CTLA-4 blockade in prostate cancer has completed with results posted in …
-
CLINICAL_TRIALS trial_result · 2021-01-25Clinical Trial Update: Cabazitaxel and Prednisone in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer [Phase 2]
Phase 2 trial evaluating cabazitaxel plus prednisone in metastatic hormone-resistant prostate cancer was terminated; results posted in 2021.
-
CLINICAL_TRIALS trial_result · 2021-01-25Clinical Trial Update: Validation of FACBC for Detection of Metastasis Among High-risk Prostate Cancer Patients With Presumed Localized Disease [Phase 2]
Phase 2 clinical trial update evaluating FACBC for detecting metastasis in high-risk prostate cancer patients with presumed localized diseas…
-
CLINICAL_TRIALS trial_result · 2021-01-22Clinical Trial Update: [18F]PSMA-11 PET/CT Phase 3 Clinical Study [Phase 3]
Phase 3 clinical trial update for [18F]PSMA-11 PET/CT in prostate cancer has completed.
-
CLINICAL_TRIALS trial_result · 2021-01-22Clinical Trial Update: Radiation-hormone and Docetaxel VS Radiation-hormone in Patients With High-Risk Localized Prostate Cancer [Phase 2]
Phase 2 trial comparing radiation-hormone therapy with docetaxel versus radiation-hormone therapy alone in high-risk localized prostate canc…
-
FDA approval · 2021-01-14FDA Approved: DOCETAXEL — Original Application (Hikma Pharmaceuticals USA Inc.)
FDA approves Hikma Pharmaceuticals USA Inc.'s original application for generic docetaxel. Docetaxel is a chemotherapy agent used to treat mu…
-
CLINICAL_TRIALS trial_result · 2021-01-13Clinical Trial Update: Genetic and Molecular Mechanisms in Assessing Response in Patients With Prostate Cancer Receiving Enzalutamide Therapy [Phase 2]
This Phase 2 clinical trial update investigates genetic and molecular factors associated with response to enzalutamide in prostate cancer, i…
-
CLINICAL_TRIALS trial_result · 2021-01-13Clinical Trial Update: Neoadjuvant BKM120 in High-risk Prostate Cancer [Phase 2]
A Phase 2 neoadjuvant trial evaluating BKM120 in high-risk prostate cancer was terminated; results were posted.
-
CLINICAL_TRIALS trial_result · 2021-01-08Clinical Trial Update: Consensus Method to Evaluate the Conformity of Prescription of a Chemotherapy
A completed clinical trial evaluating a consensus method to evaluate conformity of prescription for a chemotherapy regimen in prostate cance…